120 related articles for article (PubMed ID: 34274471)
1. NANOG gene suppression and replacement of let-7 modulate the stemness, invasion, and apoptosis in breast cancer.
Serej ZA; Ebrahimi A; Kazemi T; Najafi S; Amini M; Nastarin P; Baghbani E; Baradaran B
Gene; 2021 Oct; 801():145844. PubMed ID: 34274471
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of pancreatic cancer stem cell characteristics by α-Mangostin: Molecular mechanisms involving Sonic hedgehog and Nanog.
Ma Y; Yu W; Shrivastava A; Srivastava RK; Shankar S
J Cell Mol Med; 2019 Apr; 23(4):2719-2730. PubMed ID: 30712329
[TBL] [Abstract][Full Text] [Related]
3. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
4. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
5. Astaxanthin Reduces Stemness Markers in BT20 and T47D Breast Cancer Stem Cells by Inhibiting Expression of Pontin and Mutant p53.
Ahn YT; Kim MS; Kim YS; An WG
Mar Drugs; 2020 Nov; 18(11):. PubMed ID: 33233699
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.
Lu G; Li Y; Ma Y; Lu J; Chen Y; Jiang Q; Qin Q; Zhao L; Huang Q; Luo Z; Huang S; Wei Z
J Exp Clin Cancer Res; 2018 Nov; 37(1):289. PubMed ID: 30482236
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA FEZF1-AS1 promotes breast cancer stemness and tumorigenesis via targeting miR-30a/Nanog axis.
Zhang Z; Sun L; Zhang Y; Lu G; Li Y; Wei Z
J Cell Physiol; 2018 Nov; 233(11):8630-8638. PubMed ID: 29797562
[TBL] [Abstract][Full Text] [Related]
8. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
[TBL] [Abstract][Full Text] [Related]
9. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
10. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
[TBL] [Abstract][Full Text] [Related]
11. Induction of breast cancer stem cells by M1 macrophages through Lin-28B-let-7-HMGA2 axis.
Guo L; Cheng X; Chen H; Chen C; Xie S; Zhao M; Liu D; Deng Q; Liu Y; Wang X; Chen X; Wang J; Yin Z; Qi S; Gao J; Ma Y; Guo N; Shi M
Cancer Lett; 2019 Jun; 452():213-225. PubMed ID: 30917918
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia modulates stem cell properties and induces EMT through N-glycosylation of EpCAM in breast cancer cells.
Zhang D; Yang L; Liu X; Gao J; Liu T; Yan Q; Yang X
J Cell Physiol; 2020 Apr; 235(4):3626-3633. PubMed ID: 31584203
[TBL] [Abstract][Full Text] [Related]
13. MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b.
Roscigno G; Quintavalle C; Donnarumma E; Puoti I; Diaz-Lagares A; Iaboni M; Fiore D; Russo V; Todaro M; Romano G; Thomas R; Cortino G; Gaggianesi M; Esteller M; Croce CM; Condorelli G
Oncotarget; 2016 Jan; 7(1):580-92. PubMed ID: 26556862
[TBL] [Abstract][Full Text] [Related]
14. Intracellular Notch1 Signaling in Cancer-Associated Fibroblasts Dictates the Plasticity and Stemness of Melanoma Stem/Initiating Cells.
Du Y; Shao H; Moller M; Prokupets R; Tse YT; Liu ZJ
Stem Cells; 2019 Jul; 37(7):865-875. PubMed ID: 30941836
[TBL] [Abstract][Full Text] [Related]
15. Zoledronic acid inhibits the growth of cancer stem cell derived from cervical cancer cell by attenuating their stemness phenotype and inducing apoptosis and cell cycle arrest through the Erk1/2 and Akt pathways.
Wang L; Liu Y; Zhou Y; Wang J; Tu L; Sun Z; Wang X; Luo F
J Exp Clin Cancer Res; 2019 Feb; 38(1):93. PubMed ID: 30791957
[TBL] [Abstract][Full Text] [Related]
16. miR-16 enhances miR-302/367-induced reprogramming and tumor suppression in breast cancer cells.
Hoseinbeyki M; Taha MF; Javeri A
IUBMB Life; 2020 May; 72(5):1075-1086. PubMed ID: 32057163
[TBL] [Abstract][Full Text] [Related]
17. Signaling pathways and microRNAs, the orchestrators of NANOG activity during cancer induction.
Alemohammad H; Asadzadeh Z; Motafakker Azad R; Hemmat N; Najafzadeh B; Vasefifar P; Najafi S; Baradaran B
Life Sci; 2020 Nov; 260():118337. PubMed ID: 32841661
[TBL] [Abstract][Full Text] [Related]
18. Reduction of NANOG Mediates the Inhibitory Effect of Aspirin on Tumor Growth and Stemness in Colorectal Cancer.
Wang H; Liu B; Wang J; Li J; Gong Y; Li S; Wang C; Cui B; Xue X; Yang M; Fan W; Kang Z; Kamran M; Xu J; Tian P; Luo Y; Hou Z; Dong L; Ren Y; Li M; Wen Q; Cheng W; Xu L; Wang L; Liu Q
Cell Physiol Biochem; 2017; 44(3):1051-1063. PubMed ID: 29179207
[TBL] [Abstract][Full Text] [Related]
19. Papillary Thyroid Cancer Tumor Spheres Cultured by Passaging Without Sorting Exhibit Cancer Stemness.
Cho JM; Lee HJ; Chung JH; Kim WY; Kang MH; Ha KS; Woo SU; Lee JB
Anticancer Res; 2020 Jul; 40(7):3801-3809. PubMed ID: 32620619
[TBL] [Abstract][Full Text] [Related]
20. TGLI1 transcription factor mediates breast cancer brain metastasis via activating metastasis-initiating cancer stem cells and astrocytes in the tumor microenvironment.
Sirkisoon SR; Carpenter RL; Rimkus T; Doheny D; Zhu D; Aguayo NR; Xing F; Chan M; Ruiz J; Metheny-Barlow LJ; Strowd R; Lin J; Regua AT; Arrigo A; Anguelov M; Pasche B; Debinski W; Watabe K; Lo HW
Oncogene; 2020 Jan; 39(1):64-78. PubMed ID: 31462709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]